Scott L. Burrows serves as Executive at Arcutis Biotherapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Scott L. Burrows has executed 14 insider transactions totaling $820.5K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 9, 2026 involved receiving (via award) 140,000 shares valued at $0.
Scott L. Burrows currently holds 140,000 shares of Arcutis Biotherapeutics, Inc. (ARQT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Scott L. Burrows has been a net seller of ARQT stock. They have purchased $0 and sold $820.5K worth of shares.
Scott L. Burrows's most recent insider trade was on Jan 9, 2026, when they sold 140,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $28.17 |
| Discretionary |
| Dec 22, 2023 | SYRE | $0 | Award | 134,953 | $N/A | Discretionary |
| Mar 6, 2023 | ARQT | $4.4K | Sale | 291 | $15.26 | Discretionary |
| Mar 2, 2023 | ARQT | $297 | Sale | 18 | $16.52 | Discretionary |
| Mar 2, 2023 | ARQT | $22.4K | Sale | 1,416 | $15.82 | Discretionary |
| Mar 2, 2023 | ARQT | $0 | Award | 21,000 | $N/A | Discretionary |
| Feb 28, 2023 | ARQT | $6.7K | Sale | 416 | $16.17 | Discretionary |
| Sep 16, 2022 | ARQT | $8.4K | Option Exercise | 5,000 | $1.68 | Discretionary |
| Mar 7, 2022 | ARQT | $164 | Sale | 10 | $16.44 | Discretionary |
| Mar 4, 2022 | ARQT | $4.9K | Sale | 293 | $16.86 | Discretionary |
| Mar 3, 2022 | ARQT | $0 | Award | 13,300 | $N/A | Discretionary |
| Mar 1, 2022 | ARQT | $7.5K | Sale | 420 | $17.75 | Discretionary |
| Dec 27, 2021 | ARQT | $252.1K | Sale | 12,560 | $20.07 | Discretionary |